CoraVie Medical
CoraVie is the "CGM" of hypertension, providing day and night actionable blood pressure trends for early diagnosis and improved clinical decisions.
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location Minneapolis, MN, USA
- Currency USD
- Founded April 2020
- Employees 8
- Incorporation Type C-corp
- Website coraviemedical.com
Company Summary
CoraVie Medical is revolutionizing hypertension management with an implantable, ultrasound-based blood pressure and cardiovascular monitoring platform - providing earlier access to actionable blood pressure and cardiovascular insights, enabling faster clinical decisions, improved therapy optimization, and reduced risk of devastating events such as stroke.
We are following the same successful playbook of other implantable monitors.
Team
-
Founder & CEO30 yrs in Medtech across multiple leadership and functional roles. Significant experience that position her well to lead CoraVie, including 8 yrs in technical sales collaborating directly with cardiologists, and 8+ yrs connecting unmet needs to new innovations to create significant growth opportunities. She has experience in hypertension, heart failure, cardiac arrhythmias, and acute myocardial infarction. BSEE from UW-Madison, MBA from UMN.
-
Erik Scott, PhDChief ArchitectDr. Scott has over 30 years in the Medical Device Industry, including 25 years at Medtronic where he had responsibility for new product platforms for Neuromodulation. He is a prolific inventor in both medical devices and batteries, and he has over 75 patents to his name. Erik was inducted as a fellow of the American Institute of Medical and Biological Engineers.
Advisors
-
John Osborn, PhDUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.